Exelixis, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
EXEL Nasdaq 2836 www.exelixis.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Exelixis, Inc.

Exelixis Posts Preliminary '25 Results, Issues '26 Outlook - Jan 12th, 2026 7:33 am
Exelixis Announces Preliminary Fiscal Year 2025 Financial Results, Provides 2026 Financial Guidance and Outlines Key Priorities and Milestones for 2026 - Jan 11th, 2026 2:00 pm
Signet Jewelers, Natural Gas Services, and More Stocks See Action From Activist Investors - Jan 9th, 2026 3:18 pm
How Natera ctDNA Partnership Around STELLAR-316 At Exelixis (EXEL) Has Changed Its Investment Story - Jan 9th, 2026 1:15 am
Assessing Exelixis (EXEL) Valuation After Zanzalintinib Phase 3 Success And STELLAR-316 Trial Plans - Jan 8th, 2026 10:08 pm
Sector Update: Health Care Stocks Retreat Late Afternoon - Jan 8th, 2026 1:55 pm
EXEL Collaborates With Natera for Late-Stage Colorectal Cancer Study - Jan 8th, 2026 6:50 am
Is It Time To Reassess Exelixis (EXEL) After Strong Multi‑Year Share Price Gains - Jan 8th, 2026 6:13 am
2 Healthcare Stocks to Buy for 2026 and Beyond - Jan 8th, 2026 3:35 am
Exelixis and Natera to Collaborate on STELLAR-316, a Phase 3 Pivotal Trial of Zanzalintinib for Patients with Colorectal Cancer - Jan 7th, 2026 6:00 am
Exelixis to Present at the J.P. Morgan 2026 Healthcare Conference on January 12, 2026 - Jan 6th, 2026 2:05 pm
Klaviyo, Wingstop among Stephens Best Ideas for 2026 - Jan 3rd, 2026 5:20 am
See How Rare Bullish Inflows Lift Outliers Like Exelixis - Dec 31st, 2025 10:46 am
Does Exelixis (NASDAQ:EXEL) Deserve A Spot On Your Watchlist? - Dec 30th, 2025 4:43 am
Exelixis Near A Buy Point. Relative Strength Rating Climbs. - Dec 18th, 2025 12:19 pm
Why Is Exelixis (EXEL) Up 9% Since Last Earnings Report? - Dec 4th, 2025 9:30 am
Exelixis to Webcast Virtual 2025 Research & Development (R&D) Day on Wednesday, December 10, 2025 - Dec 3rd, 2025 2:05 pm
Exelixis (NASDAQ:EXEL) shareholders have earned a 39% CAGR over the last three years - Dec 3rd, 2025 4:05 am
2 Under-the-Radar Stocks to Buy Heading Into 2026 - Dec 1st, 2025 6:06 pm
Exploring 3 High Growth Tech Stocks In The US Market - Nov 14th, 2025 10:38 am